HSD17B12 and breast carcinoma: In this regard, a study in human breast carcinoma suggested that involvement of HSD17B12 in the growth of carcinoma cells is not necessarily linked to the peripheral E2 biosynthesis but rather to the synthesis of very long chain fatty acids (VLCFAs), such as arachidonic acid, which contributes to breast carcinoma progression [30].